Triclabendazole in the treatment of human fascioliasis: A community-based study

Eastern Mediterranean Health Journal

Volumn 5, Issue 5, 1999, Pages 888-894

  El Morshedy, H ^a   Farghaly, A ^a   Sharaf, S ^b   Abou Basha, L ^c   Barakat, R ^a  

^a High Institute of Public Health Egypt   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; TRICLABENDAZOLE;

ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; CHOLESTASIS; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; EGYPT; ENDEMIC DISEASE; ENZYMOLOGY; FASCIOLIASIS; FEMALE; HUMAN; LIVER FUNCTION TEST; MALE; MIDDLE AGED; PARASITOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTHELMINTICS; BENZIMIDAZOLES; CHILD; CHILD, PRESCHOOL; CHOLESTASIS; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; EGYPT; ENDEMIC DISEASES; FASCIOLIASIS; FEMALE; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0033186819     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Farag HF et al. A focus on human fascioliasis in the Nile delta, Egypt. Journal of tropical medicine and hygiene, 1979, 9:88-90.
2. Control of foodborne trematode infections. Report of a WHO Study Group. Geneva, World Health Organization, 1995 (Technical Report Series, No. 849).
3. El-Sahn F et al. Human fascioliasis in an Egyptian village: prevalence and some epidemiological determinants. Journal of the Egyptian Public Health Association, 1995, LXX(5):541-57.
4. Farag HF. Human fascioliasis: a public health problem. Medicine and the community, 1994, 1:2-3.
5. Campbell WC, Rew RS. Chemotherapy of parasitic diseases. New York, Plenum Press, 1986.
6. Facy RV, Marsden PD. Fascioliasis in man. An outbreak in Hampshire. British medical journal, 1960, ii:619-25.
7. Chen MG, Mott KE. Progress in assessment of morbidity due to Fasciola hepatica infection. Tropical diseases bulletin, 1990, 87:1-38.
8. Farid Z et al. Unsuccessful use of praziquantel to treat acute fascioliasis in children. Journal of infectious diseases, 1986, 154:920-1.
9. Apt W et al. Tratamiento de la fascioliasis cronica del hombre con albendazol. [Treatment with albendazole of men with chronic fascioliasis.] Parasitología al día: boletín bibliográfico, 1991, 15:54-6.
10. Boray JC et al. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary record, 1983, 113(14):315-7.
11. Apt W et al. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. American journal of tropical medicine and hygiene, 1995, 52(6):532-5.
12. Bacq Y et al. Successful treatment of acute fascioliasis with bithionol. Hepatology, 1991, 14:1066-8.
13. Farid Z et al. The treatment of acute Fasciola hepatica infection in children. Tropical and geographical medicine, 1990, 42:95-6.
14. Boray JC, Strong MB, Allison J. Chemotherapy of fascioliasis. In: Abstracts of the Meeting of the Australian Society of Parasitology, Perth, 13-15 May, 1981. Australia, Australian Society of Parasitology, 1981:20.
15. Boray JC et al. Chemoprophylaxis of fascioliasis in sheep and cattle. Paper presented at the 9th International Conference of the World Association for Advances in Veterinary Parasitology, Budapest, 13-17 July 1981.
16. Boray JC. Chemotherapy of fascioliasis. New South Wales veterinary proceedings, 1982, 18:42-7.
17. Markwalder K et al. Infektion mit Fasciola hepatica. Erfolgreiche Therapie mit Triclabendazol. [Fasciola hepatica infection. Successful therapy using triclabendazole.] Schweizerische medizinische wochenschrift, 1988, 118:1048-52.
18. Hammouda NA et al. Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt: a preliminary study. Journal of the Egyptian Society of Parasitology, 1995, 25:137-43.
19. Laird PP, Boray JC. Human fascioliasis treated with triclabendazole. Australian and New Zealand journal of medicine, 1992, 22:45-7.
20. Katz N, Chaves A, Pellegrino D. A simple device for quantitative stool thick-smear technique in Schistosoma mansoni. Revista do Instituto Medicina Tropical de Sao Paulo, 1972, 14:397-400.
21. Bassiouny HK et al. Human fascioliasis in Egypt: effect of infection and efficacy of bithionol treatment. Journal of tropical medicine and hygiene, 1991, 94:333-7.
22. Farag HF et al. Bithionol (Bitin) treatment in established fascioliasis in Egyptians. Journal of tropical medicine and hygiene, 1988, 91:240-4.
23. Hussein MHM et al. Prevalence of fascioliasis among children with hepatomegaly. Alexandria journal of paediatrics, 1994, 1:137-41.
24. Wessely K et al. Human fascioliasis treated with triclabendazole (Fasinex) for the first time. Transcripts of the Royal Society of Tropical Medicine and Hygiene, 1988, 82:743-4.
25. Ripert CL. Praziquantel and Fasciola hepatica infection. Transcripts of the Royal Society of Tropical Medicine and Hygiene, 1990, 84:610.
26. D'sa CJ. Human fascioliasis. Proceedings of the Royal Society of Medicine, 1970, 63:385.
27. Grados O, Berrocal LA. Tratamienta de la distomatosis hepatica con bithionol. [Treatment of fascioliasis with bithionol.] Revista do Instituto Medicina Tropical de Sao Paulo, 1977, 19:425.
28. Ashton WLG, Boardman PL, D'sa CJ. Human fascioliasis in Shropshire. British medical journal, 1970, 3:500.